New Therapeutic Strategies against Helicobacter pylori / 대한소화기학회지
The Korean Journal of Gastroenterology
;
: 146-150, 2014.
Artigo
em Coreano
| WPRIM
| ID: wpr-89371
ABSTRACT
The standard therapy for Helicobacter pylori infection in Korea is a triple-drug regimen consisting of a proton pump inhibitor with two antibiotics such as clarithromycin, amoxicillin, and metronidazole. However, as the eradication rate of this regimen has declined over the past decade, this prompted the formulation of new therapeutic regimens. New therapeutic strategies against H. pylori infection that had been tried all over the world include sequential therapy, concomitant therapy, and tailored therapy This article will review the basic concepts and the results of previous clinical trials on the aforementioned new therapeutic regiments.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Helicobacter pylori
/
Infecções por Helicobacter
/
Claritromicina
/
Quimioterapia Combinada
/
Inibidores da Bomba de Prótons
/
Erradicação de Doenças
/
Amoxicilina
/
Antibacterianos
/
Nitroimidazóis
Limite:
Humanos
Idioma:
Coreano
Revista:
The Korean Journal of Gastroenterology
Ano de publicação:
2014
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS